Expression of interferon-β is associated with growth arrest of murine and human epidermal cells

Journal of Investigative Dermatology

Volumn 112, Issue 5, 1999, Pages 802-809

  Bielenberg, Diane R ^a   McCarty, Marya F ^a   Bucana, Corazon D ^a   Yuspa, Stuart H ^b   Morgan, David ^b   Arbeit, Jeffrey M ^c   Ellis, Lee M ^a   Cleary, Karen R ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Differentiation

Indexed keywords

BETA INTERFERON;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL DIVISION; EPIDERMIS CELL; GROWTH INHIBITION; GROWTH REGULATION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0032925239     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00566.x     Document Type: Article

References (65)

1. Abramovich C, Shulman LM, Ratovitski E, Harroch S, Tovey M, Eid P, Revel M: Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-α and IFN-β. EMBO J 13:5871-5877, 1994
2. Arbeit JM, Munger K, Howley PM, Hanahan D: Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol 68:4358-4368, 1994
3. Belhumeur P, Lanoix J, Blais Y, Forget D, Steyaert A, Skup D: Action of spontaneously produced beta interferon in differentiation of embryonal carcinoma cells through an autoinduction mechanism. Mol Cell Biol 13:2846-2857, 1993
4. Bickenbach JR, Greer JM, Bundman DS, Rothnagel JA, Roop DR: Loricrin expression is coordinated with other epidermal proteins and the appearance of lipid lamellar granules in development. J Invest Dermatol 104:405-410, 1995
5. Bielenberg DR, Fidler IJ, Bucana CD: Constitutive expression of interferon-beta in differentiated epithelial cells exposed to environmental stimuli. Cancer Biother Radiopharmaceut 13:375-382, 1998a
6. Bielenberg DR, Bucana CD, Sanchez R, Donawho CK, Kripke ML, Fidler IJ: Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 111:864-872, 1998b
7. Bielenberg DR, Bucana CD, Sanchez R, Mulliken JB, Folkman J, Fidler IJ: Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol in press, 1999
8. Borden EC, Groveman DS, Nasu T, Reznikoff C, Bryan GT: Antiproliferative activities of interferons against human bladder carcinoma cell lines in vitro. J Urol 132:800-803, 1984
9. Branca AA, Baglioni C: Evidence that types I and II interferons have different receptors. Nature 294:768-770, 1981
10. Bucana CD, Radinsky R, Dong Z, Sanchez R, Brigati DJ, Fidler IJ: A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonuclcotide probes for analysis of mdr-1 in mouse colon carcinoma cells. J Histochem Cytochem 41:499-506, 1993
11. Caruthers MH, Beaucage SL, Efcavitch JW, et al: Chemical synthesis and biological studies on mutated gene-control regions. Cold Spring Harbor Symp Quant Biol 47:411-418, 1982
12. Clemens MJ, McNurlan MA: Regulation of cell proliferation and differentiation by interferons. Biochem J 226:345-360, 1985
13. Coltrera MD, Gown AM: PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J Histochem Cytochem 39:23-30, 1991
14. Coussens LM, Hanahan D, Arbeit JM: Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol 149:1899-1917, 1996
15. De Maeyer-Guignard J, De Maeyer E: Immunomodulation by interferons: recent developments. Interferon 6:69-91, 1985
16. Dianzani F: Interferon treatments: how to use an endogenous system as a therapeutic agent. J Interferon Res 12:109-118, 1992
17. Dinney CP, Bielenberg D, Perrotte P, Reich R, Eve B, Bucana CD, Fidler IJ: Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration. Cancer Res 58:808-814, 1998
18. Dvorak HF, Gresser I: Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J Natl Cancer Inst 81:497-502, 1989
19. Fabra A, Nakajima M, Bucana CD, Fidler IJ: Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. Differentiation 52:101-110, 1992
20. Fidler IJ: Modulation of the organ microenvironment for treatment of cancer metastasis (review). J Natl Cancer Inst 87:1588-1592, 1995
21. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188, 1994
22. Fidler IJ, Kumar R, Bielenberg DR, Ellis LM: Molecular determinants of angiogenesis in cancer metastasis. Cancer J Sci Am 4:58-66, 1998
23. Friedman-Einar M, Revel M, Kimchi A: Initial characterization of a spontaneous interferon secreted during growth and differentiation of Friend crythroleukemia cells. Mol Cell Biol 2:1472-1480, 1982
24. Fujisawa H, Kondo S, Wang B, Shivji GM, Sauder DN: The expression and modulation of IFN-α and IFN-β in human keratinocytes. J Interferon Cytokine Res 17:721-725, 1997
25. Fukuzawa K, Horikoshi T: Inhibitory effect of human fibroblast interferon (HuIFN-beta) on the growth and invasive potential of cultured human melanoma cells in vitro. Br J Dermatol 126:324-330, 1992
26. Gohji K, Fidler IJ, Tsan R, Radinsky R, von Eschenbach AC, Tsuruo T, Nakajima M: Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renal-carcinoma cells. Int J Cancer 58:380-384, 1994
27. Gorlach A, Herter P, Hentschel H, Frosch PJ, Acker H: Effects of nIFN-β and rIFN-γ on growth and morphology of two human melanoma cell lines: comparison between two-and three-dimensional culture. Int J Cancer 56:249-254, 1994
28. Gray JW: Monoclonal antibodies against bromodeoxyuridine. Cytometry 6:501-673, 1985
29. Gresser I: Biologic effects of interferons. J Invest Dermatol 95:66S-71S, 1990
30. Gresser I, Camand C, Maury C, et al: Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastasis after interferon α/β treatment in mice. J Exp Med 173:1193-1203, 1991
31. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH: Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-254, 1980
32. Heyns AP, Eldor A, Vlodavsky I, Kaiser N, Fridman R, Panet A: The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Exp Cell Res 161:297-306, 1985
33. Latropoulos MJ, Williams GM: Proliferation markers. Exp Toxicol Pathol 48:175-181, 1996
34. Iruela-Arispe ML, Dvorak HF: Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 78:672-677, 1997
35. Isaacs A, Lindenmann J: Virus interference. I. The interferon. Proc R Soc Ser B 147:258-267, 1957
36. Javaherian A, Vaccariello M, Fusenig NE, Garlick JA: Normal keratinocytes suppress early stages of neoplastic progression in stratified epithelium. Cancer Res 58:2200-2208, 1998
37. Johns TG, Mackay IR, Callister KA, Hertzog PJ, Devenish RJ, Linnane AW: Antiproliferarive potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta. J Natl Cancer Inst 84:1185-1190, 1992
38. Kalvakolanu DV, Borden EC: An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest 14:25-53, 1996
39. Lengyel P: Biochemistry of interferons and their actions. Annu Rev Biochem 51:251-282, 1982
40. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. (review). Cell 64:327-336, 1991
41. Malhotra R, Stenn KS, Fernandez LA, Braverman IM: Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest 61:162-165, 1989
42. Marks F, Fürstenberger G: Proliferative responses of the skin to external stimuli. Environ Health Perspectives 101(Suppl. 5):95-102, 1993
43. Nickoloff BJ, Basham TY, Merigan TC, Morhenn VB: Antiproliferative effects of recombinant alpha-and gamma-interferons on cultured human keratinocytes. Lab Invest 51:697-701, 1984
44. Oliveira IC, Sciavolino PJ, Lee TH, Vilcek J: Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci USA 89:9049-9053, 1992
45. Oliveira IC, Mukaida N, Matsushima K, Vilcek J: Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-κB site. Mol Cell Biol 14:5300-5308, 1994
46. Pearson WR, Lipman DL: Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85:2444-2448, 1988
47. Radinsky R, Bucana CD, Ellis LM, Sanchez R, Cleary K, Brigati DJ, Fidler IJ: A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res 53:937-943, 1993
48. Resnitzky D, Yarden A, Zipon D, Kimchi A: Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell 46:31-40, 1986
49. Roop DR, Huitfeldt H, Kilkenny A, Yuspa SH: Regulated expression of differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins. Differentiation 35:143-150, 1987
50. Rossi GB: Interferons and cell differentiation. Interferon 6:31-68, 1985
51. Shi SR, Key ME, Kalra KE: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748, 1991
52. Sica G, Fabbroni L, Castagnetta L, Cacciatore M, Pavone-Macaluso M: Antiprolilerative effect of interferons on human prostate carcinoma cell lines. Urol Res 17:111-115, 1989
53. Sidky YA, Borden EC: Inhibition of angiogenesis by interferons: effects on tumor-and lymphocyte-induced vascular responses. Cancer Res 47:5155-5161, 1987
54. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ: Interferons alpha and beta downregulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92:4562-4566, 1995
55. Singh RK, Gutman M, Llansa N, Fidler IJ: Interferon-beta prevents the upregulation of interleukin-8 expression in human melanoma cells. J Interferon Cytokine Res 16:577-584, 1996
56. Stadler R, Muller R, Orfanos CE: Effect of recombinant α-interferon on DNA synthesis and differentiation of human keratinocytes in vitro. Br J Dermatol 114:273-277, 1986
57. Tamm I, Lin SL, Pfeffer LM, Sehgal PB: Interferons α and β as cellular regulatory molecules. Interferon 9:13-74, 1987
58. Tovey MG: The expression of cytokines in the organs of normal individuals: role in homeostasis. A review. J Biol Regul Homeosts Agents 2:87-92, 1988
59. Uze G, Lutfalla G, Mogensen KE: Alpha and beta interferons and their receptor and their friends and relations. J Interferon Cytokine Res 15:3-26, 1995
60. Weinberg WC, Azzoli CG, Chapman K, Levine AJ, Yuspa SH: p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene 10:2271-2279, 1995
61. Wineland M, Ahearn P, Bielenberg D, Bucana CD, Fidler IJ: Melanoma-induced epidermal hyperplasia increases angiogenesis of the lesion (abstract). Proc Am Assoc Cancer Res 39:375-376, 1998
62. Wolf HK, Dittrich KL: Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem 40:1269-1273, 1992
63. Yaar M, Karassik RL, Schnipper LE, Gilchrest BA: Effects of alpha and beta interferons on cultured human keratinocytes. J Invest Dermatol 85:70-74, 1985
64. Yarden A, Shure-Gottlieb H, Chebath J, Revel M, Kimchi A: Autogenous production of interferon-beta switches on HLA genes during differentiation of histiocytic lymphoma U937 cells. EMBO J 3:969-973, 1984
65. Yuspa SH, Kilkenny AE, Steinert PM, Roop DR: Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 109:1207-1217, 1989